BRPI0400565A - Isolated nucleic acid molecule, recombinant expression vector, host cell, method for producing an isolated recombinant antibody, recombinant antibody, and use of a recombinant antibody - Google Patents

Isolated nucleic acid molecule, recombinant expression vector, host cell, method for producing an isolated recombinant antibody, recombinant antibody, and use of a recombinant antibody

Info

Publication number
BRPI0400565A
BRPI0400565A BR0400565-1A BRPI0400565A BRPI0400565A BR PI0400565 A BRPI0400565 A BR PI0400565A BR PI0400565 A BRPI0400565 A BR PI0400565A BR PI0400565 A BRPI0400565 A BR PI0400565A
Authority
BR
Brazil
Prior art keywords
recombinant antibody
recombinant
isolated
nucleic acid
expression vector
Prior art date
Application number
BR0400565-1A
Other languages
Portuguese (pt)
Inventor
Douglas C Hooper
Bernhard Dietzschold
Original Assignee
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Jefferson filed Critical Univ Jefferson
Priority to BR0400565-1A priority Critical patent/BRPI0400565A/en
Publication of BRPI0400565A publication Critical patent/BRPI0400565A/en

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"MOLéCULA DE áCIDO NUCLEICO ISOLADA, VETOR DE EXPRESSãO RECOMBINANTE, CéLULA HOSPEDEIRA, MéTODO PARA PRODUZIR UM ANTICORPO RECOMBINANTE ISOLADO, ANTICORPO RECOMBINANTE, E, USO DE UM ANTICORPO RECOMBINANTE". Anticorpos recombinantes são apresentados. As seq³ências de ácido nucleico e de aminoácido codificado das imunoglobulinas de cadeia pesada e leve de anticorpos monoclonais humanos neutralizadores do vírus da raiva, e seu uso, são descritas."ISOLATED NUCLEIC ACID MOLECULE, RECOMBINANT EXPRESSION VECTOR, HOST STONE CELL, METHOD TO PRODUCE AN ISOLATED RECOMBINANT ANTIBODY, AND, USE OF A RECOMBINANT ANTIBODY". Recombinant antibodies are presented. The nucleic acid and encoded amino acid sequences of the heavy and light chain immunoglobulins of human rabies virus neutralizing monoclonal antibodies, and their use, are described.

BR0400565-1A 2004-02-18 2004-02-18 Isolated nucleic acid molecule, recombinant expression vector, host cell, method for producing an isolated recombinant antibody, recombinant antibody, and use of a recombinant antibody BRPI0400565A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR0400565-1A BRPI0400565A (en) 2004-02-18 2004-02-18 Isolated nucleic acid molecule, recombinant expression vector, host cell, method for producing an isolated recombinant antibody, recombinant antibody, and use of a recombinant antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0400565-1A BRPI0400565A (en) 2004-02-18 2004-02-18 Isolated nucleic acid molecule, recombinant expression vector, host cell, method for producing an isolated recombinant antibody, recombinant antibody, and use of a recombinant antibody

Publications (1)

Publication Number Publication Date
BRPI0400565A true BRPI0400565A (en) 2005-10-11

Family

ID=35062869

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0400565-1A BRPI0400565A (en) 2004-02-18 2004-02-18 Isolated nucleic acid molecule, recombinant expression vector, host cell, method for producing an isolated recombinant antibody, recombinant antibody, and use of a recombinant antibody

Country Status (1)

Country Link
BR (1) BRPI0400565A (en)

Similar Documents

Publication Publication Date Title
FI3683235T3 (en) Anti-il-33 antibodies and uses thereof
PE20050376A1 (en) ANTIBODIES TARGETING M-CSF
CL2008002349A1 (en) Human cd37-binding antibody molecule; DNA molecule that encodes it; expression vector and host cell; method of producing said antibody; pharmaceutical composition comprising it; In vitro method of suppressing cd37-expressing b cells in a population of cells.
CY1118443T1 (en) ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USES
AR046833A1 (en) ANTI-INTERLEUQUINA ANTIBODIES-10
IL310186B1 (en) Plasma kallikrein-binding proteins
AR038568A1 (en) ANTI-A BETA ANTIBODIES AND ITS USE
AR109355A2 (en) OX40 HUMAN RECEIVER UNION MOLECULES
AR075790A2 (en) ANTI-NGF ANTIBODIES NEUTRALIZING HUMANS AS SELECTIVE INHIBITORS OF THE NGF VIA (NEURAL GROWTH FACTOR)
AR052889A1 (en) ANTIBODIES AGAINST INTERLEUQUINE-1 BETA
IL273841B1 (en) Antibodies directed against CD137 and methods of use thereof
CY1114851T1 (en) IL-1BIT BINDING antibodies and their fragments
BRPI0812878C1 (en) isolated antibody or functional part thereof, vector, method for producing an antibody or a functional part thereof, for producing an antibody-producing cell and for producing an antibody capable of specifically binding to rsv, composition, and use of an antibody or functional part of it or of a composition or vector
PE20110225A1 (en) COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING COMPLEMENT PROTEIN C5
UY29573A1 (en) DIRECTED ANTIBODIES AGAINST CD20 AND ITS USES
AR040046A1 (en) ANTI-IGFR HUMAN NEUTRALIZING ANTIBODY
EA200800953A1 (en) HUMAN MONOCLONAL ANTIBODIES TO CD70
BRPI0619595A8 (en) neutralizing antibody, epitope, isolated DNA sequence, cloning or expression vector, host cell, process for producing an antibody, pharmaceutical composition, and use of a humanized or fully human neutralizing antibody
ME00812B (en) Human antibodies to human delta like ligand 4
EA200970477A1 (en) HUMAN MONOCLONAL ANTIBODIES TO BTLA AND METHODS OF APPLICATION
DE60329489D1 (en) FUSION PROTEINS HUMANIZED G250-SPECIFIC ANTIBODY AND USES THEREOF
IL273578B1 (en) Antibodies directed against 1PDL and methods of use thereof
JP2004528803A5 (en)
TW200635946A (en) Binding proteins specific for human matriptase
ATE557040T1 (en) RECOMBINANT ANTIBODIES AND COMPOSITIONS AND METHODS FOR THE PRODUCTION AND USE THEREOF

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07D Technical examination (opinion) related to article 229 of industrial property law
B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O C/C 11, 8O C/C 13, 24 E 25 DA LPI.

B09B Decision: refusal

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.